ProQR Therapeutics (NASDAQ: PRQR) Announces AI Partnership and Advisory Board Formation
Expert Analysis ProQR Therapeutics (NASDAQ: PRQR) is advancing its RNA editing technology by integrating cutting-edge artificial intelligence systems to boost discovery and innovation. This strategic move reflects broader trends in biotechnology, where AI is increasingly utilized to streamline research and development processes, potentially accelerating drug discovery timelines. The collaboration with Ginkgo Bioworks and the creation of an AI Advisory Board signal ProQR’s commitment to enhancing its proprietary Axiomer™ platform leveraging…
